Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
Definition
Stimulant withdrawal including amphetamines, methamphetamine and methcathinone is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of stimulants in individuals who have developed Stimulant dependence or have used stimulants for a prolonged period or in large amounts. Stimulant withdrawal can also occur when prescribed stimulants have been used in standard therapeutic doses. Presenting features of stimulant withdrawal may include dysphoric mood, irritability, fatigue, insomnia or (more commonly) hypersomnia, vivid and unpleasant dreams, increased appetite, psychomotor agitation or retardation, and craving for amphetamine or related stimulants.
Exclusions
- Caffeine withdrawal
(6C48.3) - Cocaine withdrawal
(6C45.4) - Synthetic cathinone withdrawal
(6C47.4)
Also indexed as
Nearby in Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.0Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone6C46.1Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone6C46.2Stimulant dependence including amphetamines, methamphetamine or methcathinone6C46.3Stimulant intoxication including amphetamines, methamphetamine or methcathinone6C46.5Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone6C46.6Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone6C46.7Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone4B4YOther specified diseases of the immune system